Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04595682 · ClinicalTrials.gov registry record · NA
Estradiol Effects on Alcohol Across the Menstrual Cycle
A NA study, sponsored by Mark Fillmore.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04595682 is a NA study that has completed, run by Mark Fillmore. The registered enrollment target is 100 participants.
The verdict
NCT04595682, a NA study, has completed, sponsored by Mark Fillmore.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will provide the first rigorous integrative test of the hypothesis that rapid rises in estradiol (a female hormone) increase the rewarding and disinhibiting effects of alcohol and that such increased sensitivity correlates with increased alcohol use. Identification of the behavioral mechanisms by which estradiol surges can increase alcohol use would provide a critical advancement of neurobiological theory of alcohol abuse in women, an understudied area, as well as provide new directions for personalization of alcohol abuse treatment in women. In this study, naturally-cycling women will be examined daily over their menstrual cycle using an integrative combination of daily ecological assessments of hormone fluctuations and alcohol use along with strategically-timed laboratory tests of their acute sensitivity to the rewarding and disinhibiting effects of a controlled dose of alcohol.
Interventions
- DRUG Placebo
- DRUG Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2024-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04595682
The ClinicalTrials.gov registry entry for NCT04595682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mark Fillmore, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04595682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04595682 about?
NCT04595682 is a clinical study titled "Estradiol Effects on Alcohol Across the Menstrual Cycle". This study will provide the first rigorous integrative test of the hypothesis that rapid rises in estradiol (a female hormone) increase the rewarding and disinhibiting effects of alcohol and that such increased sensitivity correlates with increased alcohol use. Identification of the behavioral mecha...
What is the current status of trial NCT04595682?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-03-15. Estimated completion is 2024-11-06.
What interventions are being tested in trial NCT04595682?
The interventions under investigation include: Placebo (DRUG), Alcohol (DRUG).
Who is sponsoring clinical trial NCT04595682?
This trial is sponsored by Mark Fillmore, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.